12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Basilea board of directors update

Basilea Pharmaceutica AG (SIX:BSLN), Basel, Switzerland
Business: Infectious, Dermatology, Cancer

Read the full 31 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >